Consequences of changes in BDNF levels on serotonin neurotransmission, 5-HT transporter expression and function: Studies in adult mice hippocampus

Pharmacology Biochemistry and Behavior

Volumn 90, Issue 2, 2008, Pages 174-183

  Deltheil, Thierry ^a,b   Guiard, Bruno P ^a,b   Guilloux, Jean Philippe ^a,b   Nicolas, Lorelei ^a,b   Deloménie, Claudine ^b   Repérant, Christelle ^a,b   Maitre, Erwan Le ^c   Leroux Nicollet, Isabelle ^c   Benmansour, Saloua ^d   Coudoré, François ^a,b   David, Denis J ^a,b   Gardier, Alain M ^a,b  

^a University of Paris XI   (France)

^b IPSIT   (France)

^c IFRMP 23   (France)

^d Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Antidepressant drugs; BDNF; Conventional microdialysis; Genetically modified animals; Neurogenesis; Serotonin; Zero net flux method of quantitative microdialysis

Indexed keywords

1 [5 CHLORO 1 (2,4 DIMETHOXYLPHENYLSULFONYL) 2,3 DIHYDRO 3 (2 METHOXYPHENYL) 2 OXO 1H INDOL 3 YL] 4 HYDROXY N,N DIMETHYL 2 PYRROLIDINECARBOXAMIDE; 4 (2 CHLORO 4 METHOXY 5 METHYLPHENYL) N [2 CYCLOPROPYL 1 (3 FLUORO 4 METHYLPHENYL)ETHYL] 5 METHYL N (2 PROPYNYL) 2 THIAZOLAMINE; AGOMELATINE; BRAIN DERIVED NEUROTROPHIC FACTOR; CITALOPRAM; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; MELANIN CONCENTRATING HORMONE RECEPTOR 1 ANTAGONIST; NEUROTRANSMITTER; NEUROTROPHIN; PAROXETINE; REBOXETINE; SEROTONIN; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; SNAP 94847; TRANYLCYPROMINE;

BRAIN STEM; DEGENERATIVE DISEASE; DEPRESSION; HIPPOCAMPUS; HORMONE BLOOD LEVEL; MICRODIALYSIS; NERVE CELL PLASTICITY; NERVE STIMULATION; NERVOUS SYSTEM DEVELOPMENT; NEUROCHEMISTRY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SEROTONINERGIC SYSTEM; STATISTICAL ANALYSIS; SYNAPTOSOME; TRANSGENIC ORGANISM;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CITALOPRAM; HIPPOCAMPUS; MICE; MICRODIALYSIS; PAROXETINE; RNA, MESSENGER; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

ANIMALIA; MUS; RODENTIA;

EID: 44849113474     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2007.09.018     Document Type: Review

References (41)

1. Alonso R., Griebel G., Pavone G., Stemmelin J., Le Fur G., and Soubrie P. Blockade of CRF(1) or V(1b) receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression. Mol Psychiatry 9 (2004) 278-286
2. Altar C.A., Cai N., Bliven T., Juhasz M., Conner J.M., Acheson A.L., et al. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 389 (1997) 856-860
3. Banasr M., Soumier A., Hery M., Mocaer E., and Daszuta A. Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis. Biol Psychiatry 59 (2006) 1087-1096
4. Bengel D., Johren O., Andrews A.M., Heils A., Mossner R., Sanvitto G.L., et al. Cellular localization and expression of the serotonin transporter in mouse brain. Brain Res 778 (1997) 338-345
5. Benmansour S., Owens W.A., Cecchi M., Morilak D.A., and Frazer A. Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter. J Neurosci 22 (2002) 6766-6772
6. Benmansour S., Piotrowski J.P., and Frazer A. BDNF inhibits the effect of an SSRI on serotonin clearance. Soc For Neurosci. Atlanta (2006) poster 289.4
7. Bert L., Favale D., Jego G., Greve P., Guilloux J.P., Guiard B.P., et al. Rapid and precise method to locate microdialysis probe implantation in the rodent brain. J Neurosci Methods 140 (2004) 53-57
8. Blier P. Pharmacology of rapid-onset antidepressant treatment strategies. J Clin Psychiatry 15 (2001) 12-17
9. Blier P., de Montigny C., and Azzaro A.J. Modification of serotonergic and noradrenergic neurotransmissions by repeated administration of monoamine oxidase inhibitors: electrophysiological studies in the rat central nervous system. J Pharmacol Exp Ther 237 (1986) 987-994
10. Chaput Y., Blier P., and de Montigny C. In vivo electrophysiological evidence for the regulatory role of autoreceptors on serotoninergic terminals. J Neurosci 6 (1986) 2796-2801
11. Chen H., Pandey G.N., and Dwivedi Y. Hippocampal cell proliferation regulation by repeated stress and antidepressants. NeuroReport. 17 (2006) 863-867
12. Chen Z.Y., Jing D., Bath K.G., Ieraci A., Khan T., Siao C.J., et al. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314 (2006) 140-143
13. David D.J., Klemenhagen K.C., Holick K.A., Saxe M.D., Mendez I., Santarelli L., et al. Efficacy of the MCHR1 antagonist N-[3-(1-{[4-(3,4-difluorophenoxy)phenyl]methyl}(4-piperidyl))-4-methylph enyl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocampal neurogenesis. J Pharmacol Exp Ther 321 (2007) 237-248
14. El Mansari M., Sánchez C., Chouvet G., Renaud B., and Haddjeri N. Effects of acute and long-term administration of escitalopram and citalopram on serotonin neurotransmission: an in vivo electrophysiological study in rat brain. Neuropsychopharmacology 30 (2005) 1269-1277
15. Gardier A.M., David D.J., Jego G., Przybylski C., Jacquot C., Durier S., et al. Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice. J Neurochem 86 (2003) 13-24
16. Guiard B.P., David D.J.P., Deltheil T., Chenu F., Le Maître E., Renoir T., et al. Brain-derived neurotrophic factor-deficient mice exhibit a hippocampal hyperserotonergic phenotype. Int J NeuropsychoPharmacology 11 (2007) 1-14
17. Holick K.A., Lee D.C., Hen R., and Dulawa S.C. Behavioral effects of chronic fluoxetine in BALB/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor. Neuropsychopharmacology (2007) [11 Apr], [Electronic publication ahead of print]
18. Korte M., Carroll P., Wolf E., Brem G., Thoenen H., and Bonhoeffer T. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci U S A 92 (1995) 8856-8860
19. Lyons W.E., Mamounas L.A., Ricaurte G.A., Coppola V., Reid S.W., Bora S.H., et al. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci U S A 96 (1999) 15239-15244
20. Malagie I., Trillat A.C., Douvier E., Dessalles M.C., Jacquot C., and Gardier A.M. Regional differences in the effect of the combined treatment of WAY 100635 and fluoxetine: an in vivo microdialysis study. Naunyn-Schmiedeberg's Arch Pharmacol 354 (1996) 785-790
21. Malagie I., Trillat A.C., Bourin M., Jacquot C., Hen R., and Gardier A.M. 5-HT1B autoreceptors limit the effects of selective serotonin re-uptake inhibitors in mouse hippocampus and frontal cortex. J Neurochem 76 (2001) 865-871
22. Malberg J.E., Eisch A.J., Nestler E.J., and Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20 (2000) 9104-9110
23. Mamounas L.A., Blue M.E., Siuciak J.A., and Altar C.A. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J Neurosci 15 (1995) 7929-7939
24. Manev H., Uz T., Smalheiser N.R., and Manev R. Antidepressants alter cell proliferation in the adult brain in vivo and in neural cultures in vitro. Eur J Pharmacol 411 (2001) 67-70
25. Nibuya M., Morinobu S., and Duman R.S. Regulation of BDNF and Trkb mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15 (1995) 7539-7547
26. Nibuya M., Nestler E.J., and Duman R.S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 16 (1996) 2365-2372
27. Parsons L.H., Smith A.D., and Justice Jr. J.B. The in vivo microdialysis recovery of dopamine is altered independently of basal level by 6-hydroxydopamine lesions to the nucleus accumbens. J Neurosci Methods 40 (1991) 139-147
28. Paxinos G., and Franklin K.B.J. The mouse brain in stereotaxic coordinates. 2nd Edition (2001), Academic Press
29. Pineyro G., Blier P., Dennis T., and de Montigny C. Desensitization of the neuronal 5-HT carrier following its long-term blockade. J Neurosci 14 (1994) 3036-3047
30. Romero L., Hervas I., and Artigas F. The 5-HT1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain. Neurosci Lett 219 (1996) 123-126
31. Rutter J.J., Gundlah C., and Auerbach S.B. Systemic uptake inhibition decreases serotonin release via somatodendritic autoreceptor activation. Synapse 20 (1995) 225-233
32. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301 (2003) 805-809
33. Scharfman H., Goodman J., Macleod A., Phani S., Antonelli C., and Croll S. Increased neurogenesis and the ectopic granule cells after intrahippocampal BDNF infusion in adult rats. Exp Neurol 192 (2005) 348-356
34. Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., and Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 22 8 (2002) 3251-3261
35. Siuciak J.A., Boylan C., Fritsche M., Altar C.A., and Lindsay R.M. BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration. Brain Res 710 (1996) 11-20
36. Siuciak J.A., Lewis D.R., Wiegand S.J., and Lindsay R.M. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 56 (1997) 131-137
37. Suen P.C., Wu K., Levine E.S., Mount H.T., Xu J.L., Lin S.Y., et al. Brain-derived neurotrophic factor rapidly enhances phosphorylation of the postsynaptic N-methyl-D-aspartate receptor subunit 1. Proc Natl Acad Sci U S A 94 (1997) 8191-8195
38. Suzuki S., Kiyosue K., Hazama S., Ogura A., Kashihara M., Hara T., et al. Brain-derived neurotrophic factor regulates cholesterol metabolism for synapse development. J Neurosci 27 (2007) 6417-6427
39. Szapacs M.E., Mathews T.A., Tessarollo L., Ernest Lyons W., Mamounas L.A., and Andrews A.M. Exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression. J Neurosci Methods 140 (2004) 81-92
40. Tsanov M., and Manahan-Vaughan D. Intrinsic, light-independent and visual activity-dependent mechanisms cooperate in the shaping of the field response in rat visual cortex. J Neurosci 27 (2007) 8422-8429
41. Wu K., Xu J.L., Suen P.C., Levine E., Huang Y.Y., Mount H.T., et al. Functional TrkB neurotrophin receptors are intrinsic components of the adult brain postsynaptic density. Brain Res Mol Brain Res 43 (1996) 286-290